XML 12 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2025
Dec. 31, 2024
CURRENT ASSETS:    
Cash $ 4,602 $ 3,629
Note receivable, net 105,326
Assets from discontinued operations 577,581
Total Assets 4,602 686,536
CURRENT LIABILITIES:    
Accounts payable and accrued liabilities 8,964 26,381
Accrued compensation 56,666
Due to related parties 6,500 826
Notes payable 216,960
Derivative liability 189,014 510,154
Liabilities from discontinued operations 26,161
Total Current Liabilities 217,242 1,243,911
Total Liabilities 217,242 1,243,911
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS’ DEFICIT:    
Series A Preferred stock, 200,000 shares authorized, $0.001 par value; 100,000 and 100,000 issued and outstanding, respectively 100 100
Common stock, 2,499,900,000 shares authorized, $0.001 par value; 63,931,929 and 1,049,794 issued and outstanding, respectively 63,932 1,048
Additional paid-in capital 3,938,196 2,501,362
Stock payable 20,289 36,130
Accumulated deficit (4,235,157) (3,096,015)
Total Stockholders’ Deficit (212,640) (557,375)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT 4,602 686,536
Related Party [Member]    
CURRENT LIABILITIES:    
Convertible notes payable 4,150 74,501
Accrued interest 279  
Nonrelated Party [Member]    
CURRENT LIABILITIES:    
Convertible notes payable 7,841 317,452
Accrued interest $ 494 $ 14,810